Professional Documents
Culture Documents
Journal of Health Politics, Policy and Law, Vol. 26, No. 5, October 2001. Copyright 2001 by
Duke University Press.
JHPPL 26.5 20 Peterson 10/29/01 4:42 PM Page 1146
best be served, and at what price (Freidson 1970: 45, 368; Starr 1982).
All features of medical service in any method of medical practice,
stated a 1934 resolution adopted by the American Medical Associations
House of Delegates, should be under the control of the profession. No
other body or individual is legally or educationally equipped to exercise
such control (quoted in Millenson 1997a: 188). In Steven Brints (1994:
36) terms, medicine combined civic-minded moral appeals and circum-
scribed technical appeals to project social trustee professionalism.
What undergirds faith in our individual physicians thus empowers them
collectively in issues that are as removed from explicit medical practice
as taxation, allocative fairness, public administration, and political
accountability issues on which other legitimate interests and the pop-
ulation as a whole may in fact have quite different positions than those
promulgated by medical practitioners themselves.
Just about twenty years after Arrows seminal analysis, with trust
posed as a societal response to fill a crucial gap in the market, Paul Starr
won the 1984 Pulitzer Prize for his historical and sociological study of
how American medicine waged a long-term battle to gain scientifically
grounded legitimacy and establish its professional dominance over clin-
ical practice (physician-patient dyadic engagement), medical organiza-
tion (the structure and leadership of health care institutions), and health
care financing (the sources and arrangements for paying medical costs)
(1982). In this struggle physicians were neither predetermined victors
nor simply serving, by societal design or structural-function adaptabil-
ity of social institutions, the interests of the larger community (see Elliott
1972: 6). They had to successfully make exclusive claims to science and
medical efficacy liking to view themselves, notes Brint (1994: 59), as
applied scientists and do so at the expense of the range of competing
practitioners they confronted at the end of the nineteenth century. Estab-
lishing its scientific roots (and disparaging those of others), organized
medicine gained a legitimacy that allowed it to acquire what Starr (1982:
13) calls cultural authority, . . . [which] entails the construction of real-
ity through definitions of fact and value. In Freidsons (1970: 205 206)
words, in the course of obtaining a monopoly over its work, medicine
has also obtained well-nigh exclusive jurisdiction over determining what
illness is and therefore how people must act in order to be treated as ill.
. . . by virtue of being the authority on what illness really is, medicine
creates the social possibilities for acting sick (italics in original).
Through this domination of both its work and the social meaning and
consequences of illness, Starr argues that physicians sought to preserve
JHPPL 26.5 20 Peterson 10/29/01 4:42 PM Page 1149
Briefly stated, having the capacity to shape public policy requires pos-
sessing the kinds of attributes that matter to and could influence elected
officials, their advisers, and agency officials. A quick survey of the liter-
ature reveals a number of group characteristics that would be advanta-
geous in the political market1:
Information: Government officials who have policy-making author-
ity and are accountable to election constituencies need information
to overcome two types of uncertainty. The first involves the linkages
between proposed policy actions and actual policy outcomes as
experienced by the public. The second pertains to how ones own
constituency is likely to see and interpret what government does and
respond to it politically. Organizations representing knowledge-
based, high-status individuals or institutions earn automatic recog-
nition and have particular credibility in helping to resolve both kinds
of uncertainty.
Recurrent interactions with policy makers: The credibility of the
information provided by organized interests to policy makers it
tested through repeated interactions and the establishment of stable
relationships. In the competition among groups, active participation
in issues that are regularly on the government agenda gives an orga-
nization the opportunity to solidify impressions of its value as an
information source.
Large and dispersed membership: Because elected officials are so
sensitive to the attitudes of the districts or states they represent,
organizations have greater access and potential influence when they
include a policy makers constituents (and can make valid claims to
actually speak on their behalf ). Large and widely distributed mem-
berships or clientele expand the number of elected officials with
whom the interest will have a direct relationship. The effects are
strengthened if an organization can stimulate grassroots mobiliza-
tion. However, an interest with a large and dispersed base can also
fall victim to the collective action and free-rider problems identified
by Mancur Olson (1965) and thus need other attributes, such as an
occupational connection and selective benefits, discussed by Olson
(1965) and Walker (1991), to overcome this hurdle.
1. One could cite an extensive literature, but the main themes that follow can be found in
Arnold 1990; Bauer, Pool, and Dexter, 1972; Baumgartner and Leech 1998; Browne 1995;
Hansen 1991; Hayes 1981; Hojnacki 1997; Hula 1999; Kollman 1998; Krehbiel 1991; Olson
1965; Peterson 1993, 1995a, 1998a; Sabao 1984; Walker 1991; and Weissert and Weissert 1996.
JHPPL 26.5 20 Peterson 10/29/01 4:42 PM Page 1151
than a couple, and they may even be in conflict with one another (for
example, as noted earlier, a large membership can interfere with develop-
ing a unified policy position and establishing niche leadership). It is
profoundly striking that at the time Arrow published his article, the Amer-
ican Medical Associationthe primary organization representing physi-
cian interests unquestionably possessed all of these attributes (see
Campion 1984). It may have been the only organized interest in America
for which that has ever been true. In addition, among the individual char-
acteristics noted earlier, the AMA quite simply stood out among other
interests. When Arrow was surveying the health care marketplace, orga-
nized medicine had almost no worthy competitors for providing policy
makers with substantive information about medicine and its practice. The
trust that individuals felt toward their personal physicians had its social
complement in the general trust extended to organized medicine in mat-
ters of public policy. Other physician societies and health organizations,
too, deferred to the AMA in this collective policy-making role. The entire
health services research and health policy research enterprise, and the
community of specialists in this domain who eventually challenged posi-
tions of the AMA, did not really begin until after 1965 and the passage of
Medicare and took years to mature (Brown 1991).
In addition, too, few organizations could compete with the reach of
organized medicine, with members in probably close to every single leg-
islative district (state or federal) and certainly every state, responsive to
requests for direct grassroots participation and able to expand the effects
of their ranks by stimulating favorable reactions among their trusting
patients. At the time, more than nine out of ten practicing physicians in
the country belonged to the AMA as well as its state associations and
county medical societies. The AMA has often spent more money than
any other group represented in the nations capital to influence govern-
ment policy (Rayak 1967; Feldstein 1977). In AMPAC (the AMA Politi-
cal Action Committee), the AMA also had the third oldest political action
committee in the country (formed just before Arrow began to write his
seminal essay); it is far and away the leading campaign contributor
among health care organizations (Weissert and Weissert 1996). Certainly
in 1963, when the Arrow article was published, the AMA was the undis-
puted leader of an alliance of physicians, hospitals, insurers, and employ-
ers that sought to shape state and federal public policies in accordance
with its interests and perspectives (Peterson 1993). It is no wonder, there-
fore, that Carol Weissert and William Weissert (1996: 97), in their open-
ing summary of health care interests groups, commented that in 1965
JHPPL 26.5 20 Peterson 10/29/01 4:42 PM Page 1153
the American Medical Association was the strongest health lobby and
probably the most powerful lobby of any kind in the country.
What did organized medicine seek to accomplish with the repeated
and sustained application of this political leverage? To use the terminol-
ogy of Arrows economist colleagues, a main objective was the acquisi-
tion of rents. In the public choice framework, physicians, as a rational,
self-interested profession, sought to get the state to use its power and
resources to their economic benefit. The foundation for this line of analy-
sis, anticipated by Arrow, was laid in 1971 by George Stigler in his arti-
cle on The Theory of Economic Regulation. Stigler emphasized indus-
try efforts to secure direct governmental subsidies, control entry, restrict
substitutes and promote complements, and engage in price-fixing. These
issues were later pursued in much greater detail, with a specific health
care application, by Paul Feldstein (1977). He hypothesized that one
would find organized medicine promoting demand increasing policies,
preferred methods of reimbursement, reductions in the price of com-
plements to the production of physician services, increases in the price
of substitutes for physicians, and restrictions in the supply of physi-
cians (chaps. 1 and 2). Like the sociologists Starr and Freidson, Feld-
stein identified a number of enacted state and federal policies from
constraints on the availability of medical education to required licensure,
from public subsidies to expand hospitals to restrictions on the practice
of chiropractic, and so forth that comport with the rent-seeking inter-
ests of organized medicine. Cause and effect are not fully drawn by Feld-
stein, but the health policy parameters of the American state, starting
with early in the twentieth century as organized medicine was consoli-
dating its legitimacy, looks a lot like those that physicians as a group
desired.
Many of these provisions, such as limiting the number of training slots
for new physicians and licensing according to the dictates of the AMA,
were sold to the public and policy makers by organized medicine as
important means for ensuring quality and preventing the practice of
quack medicine. But, as Feldstein notes, that justification loses merit
when one identifies how few policies have been put forward by organized
medicine to ensure the quality of practice once physicians have entered
the workforce and how resistant it has been to alternative approaches. In
addition, organized medicine purports to endorse a number of public
health initiatives in addition to the policies that facilitate the clinical and
economic autonomy of physicians. Where, though, does it put its politi-
cal dollars? AMPAC consistently directs campaign contributions to those
JHPPL 26.5 20 Peterson 10/29/01 4:42 PM Page 1154
2. Heinz et al. 1993; Jacobs 1993; Peterson 1993, 1995b, 1998b, and unpublished; Starr 1982;
Walker 1991; and Weissert and Weissert 1996.
JHPPL 26.5 20 Peterson 10/29/01 4:42 PM Page 1156
(Jacobs 1993). The AMA may have opposed Medicare, but with the
programs implementation, it compelled the institutionalization for a
time of usual, customary, and reasonable (UCR) retrospective reim-
bursement that served physicians economic self-interest well and fueled
subsequent medical inflation. Next came a more profound challenge to
physician dominance of health care decision making and policy. Under
the National Health Planning and Resources Development Act of 1974,
not only were competing health care providers and health policy spe-
cialists to share the decision-making stage with physicians, but also now
even consumers themselves were to have equal status in community-
level Health Systems Agencies responsible (unsuccessfully) for effective
and coordinated state and federal health policy (Morone 1990).
By the late 1980s, the AMA was just another interest group (Heinz et
al. 1993; Weissert and Weissert 1996). A vignette illustrates its decline in
clout. In 1991, a young fellow recently hired by the AMA as a lobbyist
noticed one of the most influential Democratic members of Congress in
the hallway of the Capitol and, knowing that he chaired a crucial sub-
committee, thought the occasion provided a good opportunity to intro-
duce himself and begin building a relationship. When he approached the
member of Congress, held out his hand, and cheerfully introduced him-
self and offered the upbeat line I guess well be working together, the
member of Congress looked with disdain at the extended hand and
uttered simply, Go f yourself.3 A few years later, the AMA not
only did not dominate the health care reform debate, it was hardly even
a recognized player (Peterson 1995b). Representatives of small and large
businesses, insurance plans, the pharmaceutical industry, consumer
groups, and other citizen organizations played a far more significant role
(Johnson and Broder 1996; Peterson 1998c; Skocpol 1996).
3. This story was told to me by a congressional staff member soon after it happened; at the
time I was a legislative assistant for health policy in the office of Senator Tom Daschle (D-SD).
JHPPL 26.5 20 Peterson 10/29/01 4:42 PM Page 1158
Arrows specific argument, health plans well attuned to the latest in bio-
medical research can help address the adverse consequences of informa-
tion asymmetry by compelling physicians to treat their patients in accor-
dance with the best practices, even if the patients themselves do not have
the information necessary to identify those practices. Ideally, the aggre-
gation of medical decision making in managed care plans erases infor-
mation asymmetries overall and ensures that individual patients receive
the most appropriate care.
On the other hand, there are reasons to question the veracity of this
ideal image. First, managed care plans as a group are but one claimant
to scientific legitimacy, among others, and their assertions of superiority
are potentially as self-serving and politically motivated including in
support of rent-seeking behavior as that of physicians (Belkin 1998).
One has to develop trust in private insurers, much as Arrow identified
trust in physicians, to be assured that the best interests of patients are
being pursued rather than those of the managed care organization. But
such organizations do not even have the professional foundation or per-
sonal characteristics that benefited physicians in this regard. Indeed,
because most managed care insurance carriers are now for-profit entities
and so many decisions by plans are seen by the public as motivated by
economic instead of medical considerations, the idea of granting dele-
gation and trust to insurance carriers similar to what Arrow suggested
for physicians is highly problematic (JHPPL 1998, 1999). Following a
sustained backlash against managed care, however justified, it comes as
no surprise that in 2000 only 29 percent of the public believed that man-
aged care companies were doing a good job, just one percentage point
above the assessment of the tobacco industry, the social nemesis of our
era (Blendon and Benson 2001: 40).
Second, because evidence-based medicine with its clinical practice
guidelines focuses on what is effective for the average patient present-
ing a specified set of conditions, it must ignore any idiosyncratic charac-
teristics, histories, and needs of particular patients. Therefore, the physi-
cian is once again called to the fore as a mediator between the science of
medicine, as encapsulated in managed care protocols and the treatment
of specific individuals (Tanenbaum 1994). Which returns us to trust in
physicians. Vice President Albert Gore, in his speech accepting the
Democratic partys nomination for president in 2000, captured the theme
repeated by many: Its time to take the medical decisions away from the
HMOs and insurance companiesand give them back to the physicians,
the nurses, and the health care professionals (New York Times, 18
JHPPL 26.5 20 Peterson 10/29/01 4:42 PM Page 1160
August 2000, A21). But those health care professionals, including physi-
cians, must make their decisions in the managed care context in which
they are themselves deeply embedded. A physician has to choose as both
a clinician, and perhaps a patients advocate against the insurer, and as a
businessman explicitly focused on costs and facing incentives defined
by risk sharing and payment mechanisms that directly affect the physi-
cians own bottom line (Stone 1998). If we should have been more cir-
cumspect about trust in physicians than Arrow was in 1963, it is difficult
to make a case that we should be any less concerned today.
Conclusion
If Jamie Robinson in this volume is wrong and we are not about to wit-
ness the end of asymmetrical information as a result of various mar-
ket transformations, or if Clark Havighurst is wrong and unfettered con-
tract-based competitive markets cannot work well in health care, then
other measures may be required to substitute for the trust on which
Arrow relied and one hopes with fewer pernicious social conse-
quences. Arrow writing today in response to the empirical world he
would see might well give more favor to governmental regulation or
infusion of explicit protections for patients. Ah, but is that not a pre-
scription for the same costly and distorting rent-seeking behavior asso-
ciated with organized medicine in the past? Maybe. But today neither
physicians nor the managed care industry has the political leverage that
the AMA enjoyed in Washington, D.C., and state capitals for so much of
this century. Managed care plans, and their American Association of
Health Plans (AAHP), have never experienced the trust, status, member-
ship scope, lack of informational and organizational competition, cam-
paign resources, or coalition leadership that marked organized medicine
in earlier times and allowed it to wield so much influence. They, too, are
just another interest group.
References
Arnold, R. Douglas. 1990. The Logic of Congressional Action. New Haven, CT: Yale
University Press.
Arrow, Kenneth J. 1963. Uncertainty and the Welfare Economics of Medical Care.
American Economic Review 53(5):941 973.
JHPPL 26.5 20 Peterson 10/29/01 4:42 PM Page 1161
Bauer, Raymond A., Ithiel de Sola Pool, and Lewis Anthony Dexter. 1972. American
Business & Public Policy: The Politics of Foreign Trade. Chicago: Aldine-Atherton.
Baumgartner, Frank R., and Beth L. Leech. 1998. Basic Interests: The Importance
of Groups in Politics and Political Science. Princeton, NJ: Princeton University
Press.
Belkin, Gary S. 1998. The Technocratic Wish: Making Sense and Finding Power in
the Managed Medical Marketplace. In Healthy Markets? The New Competition
in Medicare Care, ed. Mark A. Peterson. Durham, NC: Duke University Press.
Blendon, Robert J., and John M. Benson. 2001. Americans Views on Health Policy:
A Fifty-Year Perspective. Health Affairs 20(2):33 46.
Brint, Steven. 1994. In an Age of Experts: The Changing Role of Professionals in Pol-
itics and Public Life. Princeton, NJ: Princeton University Press.
Brown, Lawrence D. 1991. Knowledge and Power: Health Services Research as a
Political Resource. In Health Services Research: Key to Health Policy, ed. Eli
Ginzberg. Cambridge: Harvard University Press.
Browne, William P. 1995. Cultivating Congress: Constituents, Issues, and Interests in
Agricultural Policy Making. Lawrence: University of Kansas Press.
Campion, Frank D. 1984. The AMA and U.S. Health Policy Since 1940. Chicago:
Chicago Review Press.
Dartmouth Medical School. 1996. The Dartmouth Atlas of Health Care. Chicago:
American Hospital Publishing.
Dzur, Albert W. Forthcoming. Democratizing the Hospital: Deliberative Democratic
Bioethics. Journal of Health Politics, Policy and Law 27(2).
Elliott, Philip. 1972. The Sociology of the Professions. London: Macmillan.
Feldstein, Paul J. 1977. Health Associations and the Demand for Legislation: The
Political Economy of Health. Cambridge, MA: Ballinger.
Freidson, Eliot. 1970. Profession of Medicine: A Study of the Sociology of Applied
Knowledge. New York: Dodd, Mead.
. 1986. Professional Powers: A Study of the Institutionalization of Formal
Knowledge. Chicago: University of Chicago Press.
Gutermuth, Karen. 1999. The American Medical Political Action Committee: Which
Senators Get the Money and Why? Journal of Health Politics, Policy and Law
24(2):357 382.
Habermas, Jrgen. 1971. Toward a Rational Society. Boston: Beacon.
Hansen, John Mark. 1991. Gaining Access: Congress and the Farm Lobby,
19191981. Chicago: University of Chicago Press.
Hayes, Michael T. 1981. Lobbyists & Legislators: A Theory of Political Markets. New
Brunswick, NJ: Rutgers University Press.
Heinz, John P., Edward O. Laumann, Robert L. Nelson, and Robert H. Salisbury.
1993. The Hollow Core: Private Interests in National Policy Making. Cambridge:
Harvard University Press.
Hojnacki, Marie E. 1997. Interest Groups Decisions to Join Alliances or Work Alone.
American Journal of Political Science 41(1)61 87.
Hula, Kevin W. 1999. Lobbying Together: Interest Group Coalitions in Legislative
Politics. Washington, DC: Georgetown University Press.
JHPPL 26.5 20 Peterson 10/29/01 4:42 PM Page 1162
of Health Care Reform. Paper prepared for delivery at the annual meeting of the
Association for Health Services Research and Foundation for Health Services
Research, Chicago.
. 1998a. The Limits of Social Learning: Translating Analysis into Action. In
Healthy Markets? The New Competition in Medicare Care, ed. Mark A. Peterson.
Durham, NC: Duke University Press.
. ed. 1998b. Healthy Markets? The New Competition in Medicare Care.
Durham, NC: Duke University Press.
. 1998c. The Politics of Health Care Policy: Overreaching in an Age of Polar-
ization. In The Social Divide: Political Parties and the Future of Activist Govern-
ment, ed. Margaret Weir. New York: Russell Sage Foundation.
. Unpublished. Stalemate: Opportunities, Gambles, and Miscalculations in
Health Policy Innovation. Book manuscript.
Poen, Monte M. 1979. Harry S. Truman versus the Medical Lobby. Columbia: Uni-
versity of Missouri Press.
Rayak, Elton. 1967. Professional Power and American Medicine: The Economics of
the American Medical Association. Cleveland: World Publishing.
Sabato, Larry J. 1984. PAC Power: Inside the World of Political Action Committees.
New York: Norton.
Sharfstein, Joshua M., and Steven S. Sharfstein. 1994. Campaign Contributions from
the American Medical Political Action Committee to Members of Congress for
or against the Public Health? New England Journal of Medicine 330(1):32 37.
Skocpol, Theda. 1996. Boomerang: Clintons Health Security Effort and the Turn
Against Government in U.S. Politics. New York: Norton.
Starr, Paul. 1982. The Social Transformation of American Medicine. New York: Basic
Books.
Stigler, George J. 1971. The Theory of Economic Regulation. Bell Journal of Eco-
nomics 2(1):3 21.
Stone, Deborah A. 1998. The Doctor as Businessman: The Changing Politics of a
Cultural Icon. In Healthy Markets? The New Competition in Medicare Care, ed.
Mark A. Peterson. Durham, NC: Duke University Press.
Tanenbaum, Sandra J. 1994. Knowing and Acting in Medical Practice: The Episte-
mological Politics of Outcomes Research. Journal of Health Politics, Policy and
Law 19(1):27 44.
Walker, Jack L. 1991. Mobilizing Interest Groups in America: Patrons, Professions,
and Social Movements. Ann Arbor, MI: University of Michigan Press.
Weissert, Carol S., and William G. Weissert. 1996. Governing Health: The Politics of
Health Policy. Baltimore, MD: Johns Hopkins University Press.
Wilkerson, John D., and David Carrell. 1999. Money, Politics, and Medicine: The
American Medical PACs Strategy of Giving in U.S. House Races. Journal of
Health Politics, Policy and Law 24(2):335 355.
Wolinsky, Howard, and Tom Brune. 1994. The Serpent on the Staff: The Unhealthy
Politics of the American Medical Association. New York: Putnam.
JHPPL 26.5 20 Peterson 10/29/01 4:42 PM Page 1164